Auro Laboratories Reports Mixed Financial Results for Q1 2024, Operating Cash Flow Shows Consistent Growth

Aug 09 2024 09:01 PM IST
share
Share Via
Auro Laboratories, a microcap pharmaceutical company, has reported a flat performance in the quarter ending March 2024, with a score of -1. The company's operating cash flow has been consistently growing, but net sales and profit after tax have seen a significant decrease. Investors are advised to hold their stock and monitor future financial reports.

Auro Laboratories, a microcap pharmaceutical company, has recently announced its financial results for the quarter ending March 2024. The company's stock has been given a 'Hold' call by MarketsMOJO.

According to the financial report, Auro Laboratories has seen a flat performance in the quarter, with a score of -1 compared to 9 in the previous quarter. However, there are some positive aspects to the company's financials. The operating cash flow has been consistently growing over the past three years, with the highest amount of Rs 18.81 crore generated annually. This indicates that the company has been able to generate higher cash revenues from its business operations.

On the other hand, there are also some areas of concern for Auro Laboratories. The net sales for the quarter have fallen by 57.3% compared to the average net sales of the previous four quarters. This is a significant decrease and indicates a negative trend in the near term. Similarly, the profit after tax (PAT) for the quarter has also fallen by 61.2% compared to the average PAT of the previous four quarters. This is another negative trend for the company.

In addition, the net sales for the quarter were the lowest in the last five quarters, further highlighting the negative sales trend in the near term. However, it is important to note that these financial results are for a single quarter and may not reflect the overall performance of the company.

Overall, Auro Laboratories has shown a mixed financial performance in the quarter ending March 2024. Investors are advised to hold their stock and closely monitor the company's future financial reports for a better understanding of its performance.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News